Amkay Products Ltd vs Avience Biomedicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Amkay Products Ltd is ₹ 53 as of 27 Oct 15:30 . The P/E Ratio of Amkay Products Ltd is 0 as of March 2024 .The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 . The Market Cap of Amkay Products Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Amkay Products Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Amkay Products Ltd

Amkay Products Limited was originally incorporated as 'Amkay Products Private Limited' on October 25, 2007 with the Registrar of Companies, Mumbai.
Subsequently, the Company was converted into a Public Limited Company and the name was changed from 'Amkay Products Private Limited' to 'Amkay Products Limited' vide a fresh Certificate of Incorporation dated August 28, 2023, issued by the Registrar of Companies, Maharashtra, Mumbai. The Company manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Steel/ Plastic Lancet Needles, Air Bed, Apron, Digital Thermometer, Nebulizer, Shoe Cover, BP Monitor, Pulse Oximeter, Surgeon Cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India.

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

FAQs for the comparison of Amkay Products Ltd and Avience Biomedicals Ltd

Which company has a larger market capitalization, Amkay Products Ltd or Avience Biomedicals Ltd?

Market cap of Amkay Products Ltd is 45 Cr while Market cap of Avience Biomedicals Ltd is 138 Cr

What are the key factors driving the stock performance of Amkay Products Ltd and Avience Biomedicals Ltd?

The stock performance of Amkay Products Ltd and Avience Biomedicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amkay Products Ltd and Avience Biomedicals Ltd?

As of October 31, 2026, the Amkay Products Ltd stock price is INR ₹53.0. On the other hand, Avience Biomedicals Ltd stock price is INR ₹253.15.

How do dividend payouts of Amkay Products Ltd and Avience Biomedicals Ltd compare?

To compare the dividend payouts of Amkay Products Ltd and Avience Biomedicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.